Anti-Mullerian Hormone Role in In Vitro Fertilization Outcome

Background and objectives: The in vitro fertilization plays a significant role for human development in last decades. Anti-müllerian hormone level evaluation is indicator of ovarian reserve. The aim of this study was to assess the role of anti-müllerian hormone in assessing the quality of in vitro fertilization outcomes. Methods: It was a retrospective study implemented at in vitro fertilization center of private hospital in Erbil city, Kurdistan region-Iraq in duration of one year from 1st of October, 2022 to 30th of September, 2023 on sample of 50 infertile women underwent in vitro fertilization. The biochemical pregnancy was diagnosed through serum recognition of human chorionic gonadotrophin, while the clinical pregnancy was diagnosed by ultrasonography. The in vitro fertilization outcome was assessed in relation to anti-mullerian hormone level and other variables like demographic and hormonal status. Results: Biochemical pregnancy was positive in 80% of infertile women, while clinical pregnancy was positive in 72% of them; 24 women with ongoing pregnancy and 12 women ended with live birth pregnancy. Mean anti-mullerian hormone level was not significantly different in regard to clinical pregnancy outcome (p=0.4). The means of oocyte retrieved and embryo transferred were significantly higher among infertile women with positive clinical pregnancy (p?0.05). The anti-mullerian hormone level was positively correlated to the count of oocyte retrieved and embryo transferred. Conclusions: The serum anti-mullerian hormone level is not a predictor for in vitro fertilization quality.